Quadrature Capital Ltd lessened its holdings in Chemed Co. (NYSE:CHE – Free Report) by 42.2% during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 13,309 shares of the company’s stock after selling 9,716 shares during the period. Quadrature Capital Ltd owned about 0.09% of Chemed worth $8,549,000 at the end of the most recent reporting period.
Other institutional investors have also recently made changes to their positions in the company. Rise Advisors LLC purchased a new stake in Chemed during the first quarter valued at approximately $26,000. GAMMA Investing LLC purchased a new stake in shares of Chemed in the 4th quarter worth $37,000. Principal Securities Inc. purchased a new position in Chemed during the fourth quarter valued at $51,000. SRS Capital Advisors Inc. grew its holdings in Chemed by 110.6% during the fourth quarter. SRS Capital Advisors Inc. now owns 99 shares of the company’s stock valued at $58,000 after purchasing an additional 52 shares during the period. Finally, Mather Group LLC. bought a new stake in Chemed during the first quarter valued at about $67,000. Institutional investors own 95.85% of the company’s stock.
Chemed Stock Performance
Shares of Chemed stock traded up $8.30 during trading hours on Friday, hitting $549.27. The company’s stock had a trading volume of 132,672 shares, compared to its average volume of 107,789. Chemed Co. has a 12-month low of $492.84 and a 12-month high of $654.62. The business has a 50 day moving average price of $543.25 and a two-hundred day moving average price of $583.12. The company has a market cap of $8.32 billion, a PE ratio of 29.56, a PEG ratio of 2.23 and a beta of 0.43.
Chemed Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Tuesday, June 18th. Investors of record on Thursday, May 30th were paid a dividend of $0.40 per share. The ex-dividend date of this dividend was Thursday, May 30th. This represents a $1.60 annualized dividend and a yield of 0.29%. Chemed’s payout ratio is 8.61%.
Analyst Upgrades and Downgrades
A number of research firms have recently weighed in on CHE. Royal Bank of Canada lowered their price objective on Chemed from $712.00 to $697.00 and set an “outperform” rating on the stock in a research report on Tuesday, May 21st. StockNews.com upgraded shares of Chemed from a “hold” rating to a “buy” rating in a research report on Saturday, May 4th.
Check Out Our Latest Analysis on CHE
Insider Buying and Selling at Chemed
In other news, CEO Kevin J. Mcnamara sold 1,500 shares of the firm’s stock in a transaction dated Thursday, June 6th. The stock was sold at an average price of $544.17, for a total transaction of $816,255.00. Following the completion of the transaction, the chief executive officer now owns 107,049 shares in the company, valued at $58,252,854.33. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. In other news, CEO Kevin J. Mcnamara sold 1,500 shares of the stock in a transaction that occurred on Thursday, June 6th. The stock was sold at an average price of $544.17, for a total transaction of $816,255.00. Following the completion of the transaction, the chief executive officer now directly owns 107,049 shares in the company, valued at approximately $58,252,854.33. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Patrick P. Grace sold 284 shares of the firm’s stock in a transaction on Wednesday, June 12th. The shares were sold at an average price of $540.98, for a total transaction of $153,638.32. Following the completion of the transaction, the director now directly owns 3,270 shares of the company’s stock, valued at $1,769,004.60. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 5,784 shares of company stock worth $3,240,053. Insiders own 3.32% of the company’s stock.
Chemed Company Profile
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
Read More
- Five stocks we like better than Chemed
- Insider Buying Explained: What Investors Need to Know
- Why Call Options Volume for These 2 Stocks Spiked Together
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- MarketBeat Week in Review – 7/22 – 7/26
- How to Buy Cheap Stocks Step by Step
- 3M Surprises and Rebound Accelerates: It Isn’t Too Late To Get In
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.